Belmont and Respect for Persons: Panelists Discuss Informed Consent, Dignity, and Respect
Protecting Human Subjects 2004 Summer; (10): 9, 16
Showing items related by title, author, creator and subject.
Sachs, Greg A.; Hougham, Gavin W.; Sugarman, Jeremy; Agre, Patricia; Broome, Marion E.; Geller, Gail; Kass, Nancy; Kodish, Eric; Mintz, Jim; Roberts, Laura W.; Sankar, Pamela; Siminoff, Laura A.; Sorenson, James; Weiss, Anita (2003-09)
Agre, Patricia; Campbell, Frances A.; Goldman, Barbara D.; Boccia, Maria L.; Kass, Nancy; McCullough, Laurence B.; Merz, Jon F.; Miller, Suzanne M.; Mintz, Jim; Rapkin, Bruce; Sugarman, Jeremy; Sorenson, James; Wirshing, Donna (2003-09)
Holcomb, John B; Weiskopf, Richard; Champion, Howard; Gould, Steven A; Sauer, R Michelle; Brasel, Karen; Bochicchio, Grant; Bulger, Eileen; Cotton, Bryan A; Davis, Daniel; Dutton, Richard; Hauser, Carl J; Hess, John R; Hides, George A; Knudson, Paula; MacKenzie, Ellen; McGinnis, Robert L; Michalek, Joel; Moore, Frederick A; Omert, Laurel; Pollock, Brad H; Tortella, Bartholomew; Sugarman, Jeremy; Schreiber, Martin A; Wade, Charles E (2011-02)Selection of study endpoints is one of the most important decisions in the design of effective clinical trials. Late mortality (e.g., 28 days) is an unambiguous endpoint, accepted by regulatory agencies, but it is viewed ...